Overview
Study information
| Network: | GHDC |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase II |
| Species: | Human |
| Stage: | In progress |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase IIb, double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and immunogenicity of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 against TB disease, in adults aged 18-50 years, living in a TB endemic region
Description
M72 TB case control (VS-ID52-Frahm) is an immune correlates analysis of M72 vaccinees enrolled in TUBERCULOSIS-018.
Sign in to see full information about this study and to download study data.